Aktis Oncology, Inc. ($AKTS)
Filing Information
| Accession Number | 0001193125-26-401014 |
|---|---|
| Form Type | 4 |
| Filing Date | Sep 24, 2026 |
| Document | View SEC Filing |
Transactions
4
Total Shares
37,500
Total Value
$320,495.99
Transactions
| Name | Title | Security | Derivative | Transaction Date | Type | Shares | Price | Total Cost | Shares After | Direct/Indirect | Nature of Ownership | Actions |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
Chief Medical Officer | Common Stock | โ | Sep 23, 2026 | Exercise/Conversion | 12,500 | $4.95 | $61,875.00 | 12,500 | Direct | โ | View Details | |
Chief Medical Officer | Common Stock | โ | Sep 23, 2026 | Sale | 5,099 | $20.19 | $102,972.78 | 7,401 | Direct | โ | View Details | |
Chief Medical Officer | Common Stock | โ | Sep 23, 2026 | Sale | 7,401 | $21.03 | $155,648.21 | 0 | Direct | โ | View Details | |
Chief Medical Officer | Stock Option (Right to Buy) | Derivative | Sep 23, 2026 | Exercise/Conversion | 12,500 | $0.00 | $0.00 | 208,718 | Direct | โ | View Details |